Search results for: 'workforce identity and access managements'
- Related search terms
- Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026
- AND 6153=5227-- cSlQ
- AND (SELECT (CASE WHEN (3989=1399) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,3989) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (4327=4327) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,4327) END) FROM DUAL) IS NULL
- Workforce engagement management (WEM) drives performance, agent engagement, and an improved customer experience (CX) in the cont
-
01 Jun 2026  |  Global  |  Market Research
Biopharma Patient Access Market, Global, 2026
Access-Controlled Commercialization is Experiencing Transformational Growth due to Rising Specialty Therapy Complexity
The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...
$2,450.00 -
08 Jul 2026  |  Global  |  Technology Research
Precision Obesity Management: AI-Guided Metabolic Modulation
Emerging Innovations Driving Personalized and Effective Obesity Solutions
The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...
$4,950.00 -
02 Mar 2017  |  Global  |  Technology Research
Biomarkers Enabling Diabetes and Obesity Management
Novel Biomarker Research is Likely to Transform the Future of Obesity and Diabetes Management
Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management ...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Jul 2026  |  Global  |  Frost Radar
Frost Radar™: Life Sciences Regulatory Information Management Platforms, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical device industries. What started in the late 1990s as a...
$4,950.00 -
22 Sep 2025  |  Global  |  Technology Research
Growth Opportunities in Weight Management Technologies
Emerging Innovations Driving Personalized and Effective Obesity Solutions
This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...
$4,950.00 -
16 Oct 2025  |  Global  |  Technology Research
Growth Opportunities in Functional Ingredients Targeting Mental and Emotional Well-Being, 2025-2030
Innovative Strategies Driving the Future of Mental and Emotional Well-Being
The study presents an in-depth exploration of novel functional ingredients designed to enhance mental and emotional well-being, identifying the overall drivers of growth, technological change, and market opportunities through 2030. Mental health disorders continue to present a serious global challenge, with anxiety and depression affecting more tha...
$4,950.00 -
08 Sep 2025  |  Global  |  Market Research
Growth Opportunities in Global Protein and Peptide Therapeutics, Forecast to 2030
Cross-Therapeutic Expansion is Driving Transformational Growth Fueled by Novel Formats and Smarter Delivery
The protein and peptide therapeutics industry is undergoing a profound transformation, driven by next-generation biologics, including multi-specific antibodies, antibody-drug conjugates (ADCs), and GLP-1 treatments. These advances are intensifying competition, while the patent expiries of blockbuster antibodies are accelerating the entry of biosimi...
$4,950.00 -
19 Dec 2025  |  Global  |  Technology Research
Emerging AI-Driven Platforms and Next-Generation Therapeutics: Innovations in Healthcare Analytics, Drug Discovery, Cancer Therapeutics, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision medicine. It highlights AI-driven platforms, advanced biologics, and digital health solutions that address critical challenges in accessibili...
$950.00 -
17 Feb 2026  |  Global  |  Market Research
Global Precision Cardiology Market: Trends and Growth Opportunities
Cross-industry Collaborations and Adoption of Cutting-edge Digital Tools and Technologies are Propelling Market Growth
Cardiovascular diseases (CVDs) remain the leading cause of global morbidity and mortality, with reported cases having doubled since 1990. Today, CVDs account for 1 in 3 deaths worldwide, representing 32% of total global mortality, with heart attacks and ischemic strokes responsible for approximately 85% of these outcomes. The rising burden is stron...
$2,450.00 -
15 May 2025  |  Global  |  Market Research
Immunomodulator Therapeutics Market, Global, 2024–2030
Mechanism-targeted Approaches are Driving Transformational Growth by Enabling Innovation in Autoimmune, Oncology, and Inflammatory Therapies
This research service offers a comprehensive analysis of the global immunomodulator therapeutics market, specifically targeting inflammatory disorders in the immunology, gastrointestinal (GI), and dermatology segments. The report defines this market through products designed to modify and regulate pathological immune responses, either by inhibiting...
$4,950.00
Special Price $4,455.00 save 10 %